Zurueck zur Suche

Reporte zur Charge TN7S9

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

9Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 2 GA 1 VA 1 SD 1 ID 1 TX 1 MI 1 CT 1

VAERS 1350431

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge TN7S9

mild
Staat
GA
Alter
0,3
Geschlecht
M
Eingang
26.05.2021
Impfdatum
11.05.2021
Beginn
12.05.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Pyrexia

Symptomtext

Patient was given 2 doses of polio accidently. Patient had a fever the next day, which subsided same day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
GERD
Andere Medikamente
famotidine 40 mg/5 mL (8 mg/mL) oral suspension TAKE 0.2 ML BY MOUTH TWICE DAILY hydrocortisone 1 % topical cream APPLY CREAM EXTERNALLY TO AFFECTED AREA EVERY 12 HOURS
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1347816

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge TN7S9

mild
Staat
CA
Alter
0,3
Geschlecht
M
Eingang
25.05.2021
Impfdatum
11.05.2021
Beginn
11.05.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Pyrexia

Symptomtext

PATIENT RECEIVED A DUPLICATE DOSE OF IPV IN THE SAME VISIT. VACCINES ADMINISTERED DURING VISIT WERE: PEDIARIX, IPV, PCV 13, HIB, ROTATEQ. PATIENTS MOTHER WAS NOTIFIED BY PROVIDER WHEN ERROR WAS NOTED. AS PER PATIENTS MOTHER, PATIENT HAD A LOW GRADE FEVER THE EVENING HE RECEIVED THE VACCINES. NO OTHER ADVERSE REACTIONS NOTED AS PER PATIENTS MOTHER.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 968911

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge TN7S9

mild
Staat
VA
Alter
0,5
Geschlecht
F
Eingang
24.01.2021
Impfdatum
11.01.2021
Beginn
11.01.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Rash Urticaria

Symptomtext

Mild facial hives/rash noted roughly 10-15 minutes after getting vaccination. Patient was referred to local ER. Rash/hives self resolved per family several hours later. Pt did not get any treatment for rash since family left ER prior to being seen.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 966598

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge TN7S9

mild
Staat
CA
Alter
0,3
Geschlecht
M
Eingang
22.01.2021
Impfdatum
12.01.2021
Beginn
21.01.2021
Tage bis Beginn
9,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Abdominal mass Crying Infant irritability Intussusception Ultrasound scan abnormal Vomiting

Symptomtext

Intussusception (ileo-ileal). 1 week of increasing fussiness and emesis requiring smaller feeds. Ultimately became inconsolable for 3 hours on 1/21/21, so Mother brought him into the ED. Found to have intussusception in LUQ on ultrasound.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vomiting
Hospital-Tage
1,0
Labordaten
1/22/21 337am: ** FINDINGS **: BOWEL: There is a mass in the left upper quadrant measuring approximately 1.5 x 1.6 cm. During real-time examination, the mass appears to form and resolve, and may represent an ongoing transient intussusception.
Aktuelle Erkrankungen
Possible nasal congestion around the time of vaccination
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2398142

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge TN7S9

gering
Staat
SD
Alter
0,5
Geschlecht
M
Eingang
01.08.2022
Impfdatum
01.08.2022
Beginn
01.08.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Unevaluable event

Symptomtext

NONE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2394580

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge TN7S9

gering
Staat
ID
Alter
0,2
Geschlecht
F
Eingang
28.07.2022
Impfdatum
21.06.2022
Beginn
21.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

that an expired dose of Pediarix had been administered on 21Jun2022 to a 2 month old female patient.; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 2-month-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number TN7S9, expiry date 29th May 2022) for prophylaxis. Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 21st June 2022, the patient received the 1st dose of Pediarix and Pediarix Pre-Filled Syringe Device. On 21st June 2022, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 18-JUL-2022 Reporter's comment: The nurse administrator reported that upon performing inventory and review, she discovered that the patient was administered a dose of Infanrix, which had an expiration date of 29th May 2022 to a 2 month old patient. This was the patient's first dose in the series. At the time of reporting, the dose had not been repeated. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. Additional supportive information: The patient had received an expired dose of Infanrix, which led to expired vaccine used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1747630

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge TN7S9

gering
Staat
TX
Alter
57,0
Geschlecht
M
Eingang
30.09.2021
Impfdatum
01.09.2021
Beginn
01.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

patient given Pediarix, 01-SEP-2021; patient given Pediarix instead of Twinrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 57-year-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number TN7S9, expiry date 29th May 2022) for prophylaxis. Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 1st September 2021, the patient received Pediarix and Pediarix Pre-Filled Syringe Device. On 1st September 2021, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The nurse reported that a patient inadvertently was given Pediarix instead of Twinrix, which led to wrong vaccine administered. The patient received Pediarix at inappropriate age which led to inappropriate age at vaccine administration. The reporter consented to follow.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1656266

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge TN7S9

gering
Staat
MI
Alter
5,0
Geschlecht
F
Eingang
30.08.2021
Impfdatum
18.08.2021
Beginn
18.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Wrong product administered

Symptomtext

No adverse events reported as of 8/30/21. Patient was given DTaP-Hep B-IPV (Pediarix) and IPV vaccinations instead of DTaP and IPV.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 1390668

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge TN7S9

gering
Staat
CT
Alter
1,5
Geschlecht
F
Eingang
11.06.2021
Impfdatum
07.06.2021
Beginn
07.06.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

administrated with Infanrix and Pediarix on the same day; This case was reported by a nurse via call center representative and described the occurrence of overdose in a 18-month-old female patient who received DTPa (Infanrix) (batch number 5RM39, expiry date 25th November 2022) for prophylaxis. Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa-HBV-IPV (Pediarix) (batch number TN7S9, expiry date 29th May 2022) for prophylaxis and dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 7th June 2021, the patient received Infanrix, Infanrix Pre-Filled Syringe Device, Pediarix and Pediarix Pre-Filled Syringe Device. On 7th June 2021, unknown after receiving Infanrix, Infanrix Pre-Filled Syringe Device, Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced overdose. On an unknown date, the outcome of the overdose was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: Nurse reported that a patient was administrated with Infanrix and Pediarix on the same day, which led to overdose. No adverse event was reported . The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-